OpenSourceMalaria:Compound Series: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Matthew Todd (talk | contribs) (added epigenetic regulation of lifecycle page) |
Anthony Sama (talk | contribs) No edit summary |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
A summary of progress in the OSM project may be found in the [[OpenSourceMalaria:Story_so_far|Story so Far]]. The pages below include the technical detail of the individual series examined and are written for scientific contributors. | A summary of progress in the OSM project may be found in the [[OpenSourceMalaria:Story_so_far|Story so Far]]. The pages below include the technical detail of the individual series examined and are written for scientific contributors. | ||
[[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] ( | [[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] (Paper has been released: http://pubs.acs.org/doi/full/10.1021/acscentsci.6b00086) | ||
[[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] (parked) | [[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] (parked) | ||
[[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] ( | [[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] (parked) | ||
[[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines (TPs)''']] ( | [[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines (TPs)''']] (current thread of work) | ||
[[OpenSourceMalaria:Triazolopyrazine_Series Mechanism of Action |'''Series 4: Mechanism of Action''']] | |||
[[OpenSourceMalaria:Synthesis Branches |'''Synthetic Branches''']] | |||
[[OpenSourceMalaria:Obtaining Compounds for OSM |'''Obtaining Compounds for OSM''']] | [[OpenSourceMalaria:Obtaining Compounds for OSM |'''Obtaining Compounds for OSM''']] | ||
| Line 16: | Line 20: | ||
[[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | [[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | ||
[[OpenSourceMalaria:Other Possible Series and Targets | '''Other Possible Series and Targets''']] | |||
[[OpenSourceMalaria:Epigenetic Regulation of Life Cycle | '''Epigenetic Regulation of Lifecycle''']] | [[OpenSourceMalaria:Epigenetic Regulation of Life Cycle | '''Epigenetic Regulation of Lifecycle''']] | ||
Revision as of 15:33, 12 February 2017
A summary of progress in the OSM project may be found in the Story so Far. The pages below include the technical detail of the individual series examined and are written for scientific contributors.
Series 1: GSK Arylpyrroles (Paper has been released: http://pubs.acs.org/doi/full/10.1021/acscentsci.6b00086)
Series 2: GSK Triazoloureas (parked)
Series 3: GSK Thienopyrimidines (parked)
Series 4: Triazolopyrazines (TPs) (current thread of work)
